There is one resource available
103P - Enhancing survival prediction in advanced non-small cell lung cancer (aNSCLC): A comparison of artificial intelligence (AI) derived prognostication and RECIST assessments in MYSTIC phase III trial
Presenter: Omar Khan
Session: Poster Display session